Reduction of "no-reflow" phenomenon by intra-aortic balloon counterpulsation in a randomized magnetic resonance imaging experimental study

Journal of the American College of Cardiology

Volumn 43, Issue 7, 2004, Pages 1291-1298

  Amado, Luciano C ^a   Kraitchman, Dara L ^a   Gerber, Bernhard L ^a   Castillo, Ernesto ^a   Boston, Raymond C ^b   Grayzel, Joseph ^c   Lima, João A C ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Datascope Corporation   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Contrast enhanced magnetic resonance imaging; IABC; Intra aortic balloon counterpulsation; Left ventricle ventricular; LV; MBF; MI; Microvascular obstruction or "no reflow phenomenon"; MO; MRI; Myocardial blood flow; Myocardial infarction; TTC

Indexed keywords

MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA BALLOON; ARTICLE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; COUNTERPULSATION; DOG; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPERFUSION; STATISTICAL SIGNIFICANCE;

ANIMALS; BLOOD PRESSURE; COLORING AGENTS; CORONARY CIRCULATION; COUNTERPULSATION; DISEASE MODELS, ANIMAL; DOGS; INTRA-AORTIC BALLOON PUMPING; MAGNETIC RESONANCE IMAGING; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; TETRAZOLIUM SALTS; TREATMENT OUTCOME;

EID: 1842478187     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.11.034     Document Type: Article

References (28)

1. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction: the GUSTO investigators. N Engl J Med 1993;329:673-682
2. Rezkalla S.H., Kloner R.A. No-reflow phenomenon. Circulation. 105:2002;656-662.
3. Rochitte C.E., Lima J.A., Bluemke D.A., et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation. 98:1998;1006-1014.
4. Ito H., Maruyama A., Iwakura K., et al. Clinical implications of the "no reflow" phenomenon A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 93:1996;223-228.
5. Wu K.C., Zerhouni E.A., Judd R.M., et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 97:1998;765-772.
6. Anderson R.D., Ohman E.M., Holmes D.R. Jr, et al. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock Observations from the GUSTO-I study. Global utilization of streptokinase and TPA for occluded coronary arteries. J Am Coll Cardiol. 30:1997;708-715.
7. Kono T., Morita H., Nishina T., et al. Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy. J Am Coll Cardiol. 28:1996;876-881.
8. Ohman E.M., George B.S., White C.J., et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction Results of a randomized trial: the randomized IABP Study Group. Circulation. 90:1994;792-799.
9. Talley J.D., Ohman E.M., Mark D.B., et al. Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction The Randomized Intraaortic Balloon Pump Study Group. Am J Cardiol. 79:1997;590-594.
10. Slavin G.S., Wolff S.D., Gupta S.N., et al. First-pass myocardial perfusion MR imaging with interleaved notched saturation Feasibility study. Radiology. 219:2001;258-263.
11. Simonetti O.P., Kim R.J., Fieno D.S., et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 218:2001;215-223.
12. Domenech R.J., Hoffman J.I., Noble M.I., et al. Total and regional coronary blood flow measured by radioactive microspheres in conscious and anesthetized dogs. Circ Res. 25:1969;581-596.
13. Reimer K.A., Jennings R.B. The changing anatomic reference base of evolving myocardial infarction Underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage and acute inflammation. Circulation. 60:1979;866-876.
14. Rousseeuw P.J., Leroy A.M. Robust Regression and Outlier Detection. 1987;Wiley, New York.
15. Hamilton L.C. Regression With Graphics A second course in applied statistics. 1992;Duxbury Press, Belmont, CA.
16. Kloner R.A., Ganote C.E., Jennings R.B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 54:1974;1496-1508.
17. Ambrosio G., Weisman H.F., Mannisi J.A., et al. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 80:1989;1846-1861.
18. Bolognese L., Cerisano G. Early predictors of left ventricular remodeling after acute myocardial infarction. Am Heart J. 138:1999;S79-S83.
19. Gerber B.L., Rochitte C.E., Melin J.A., et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation. 101:2000;2734-2741.
20. Sala M.F., Barcena J.P., Rota J.I., et al. Sustained ventricular tachycardia as a marker of inadequate myocardial perfusion during the acute phase of myocardial infarction. Clin Cardiol. 25:2002;328-334.
21. Gerber B.L., Garot J., Bluemke D.A., et al. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation. 106:2002;1083-1089.
22. Lima J.A., Judd R.M., Bazille A., et al. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI Potential mechanisms. Circulation. 92:1995;1117-1125.
23. Michaels A.D., Gibson C.M., Barron H.V. Microvascular dysfunction in acute myocardial infarction Focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol. 85:2000;50B-60B.
24. White H.D. Future of reperfusion therapy for acute myocardial infarction. Lancet. 354:1999;695-697.
25. Mahaffey K.W., Puma J.A., Barbagelata N.A., et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction Study of Adenosine (amistad) trial. J Am Coll Cardiol. 34:1999;1711-1720.
26. Stone G.W., Marsalese D., Brodie B.R., et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty Second Primary Angioplasty in Myocardial Infarction (PAMI-II) trial investigators. J Am Coll Cardiol. 29:1997;1459-1467.
27. Wu K.C., Kim R.J., Bluemke D.A., et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol. 32:1998;1756-1764.
28. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 100:1999;1992-2002.